Randomized Controlled Trial
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Jun 16, 2017; 9(6): 273-281
Published online Jun 16, 2017. doi: 10.4253/wjge.v9.i6.273
Table 1 Characteristics of patients and colonoscopy performance in both groups n (%)
ParametersbNBI (n = 495)WLE (n = 511)P value
Patients
Men210 (42.43)237 (46.38)0.207
Age, mean ± SD58.31 ± 6.1758.36 ± 6.130.904
BMI, mean ± SD23.75 ± 3.2923.74 ± 2.990.942
Current smoker24 (4.9)29 (5.7)0.536
Current drinker38 (7.7)44 (8.7)0.815
Current use of NSAID6 (1.2)9 (1.8)0.705
Current use of aspirin13 (2.6)22 (4.3)0.345
Current use of warfarin02 (0.4)0.232
Comorbidities
Hypertension123 (24.8)131 (25.6)0.774
Diabetes56 (11.3)32 (6.3)0.005
Ischemic heart disease10 (2.0)10 (2.0)0.943
Chronic obstructive airway disease2 (0.4)00.15
Previous stroke1 (0.2)2 (0.4)0.582
Cirrhosis1 (0.2)1 (0.2)0.982
Gastro-esophageal reflux10 (2)8 (1.6)0.587
Dyslipidemia31 (6.3)29 (5.7)0.694
History of cancer19 (3.8)12 (2.3)0.172
Examination time (min), mean ± SD
Time to cecum6.66 ± 4.567.06 ± 4.940.183
Time for withdrawal11.23 ± 6.369.84 ± 5.03< 0.0001